Oncternal Therapeutics, Inc. Confirms Lentigen Technology, Inc. to Manufacture Lentiviral Vectors for Its ROR1-targeting CAR-T Cell Therapy Program

NEXT STORY
Emergency Medical Supplies Market to reach US $440.11 billion by 2028 – Global Insights on Key Trends, COVID-19 Impact Analysis, Growth Opportunities, Expansion Plans and Future Prospect: Adroit Market Research
PREV STORY
Innovation Pharmaceuticals’ Brilacidin for the Treatment of COVID-19 Receives FDA Fast Track Designation
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

New Nursing Study Shows Exergen Temporal Artery Thermometer Increases Patient, Family and Provider Satisfaction; Speeds Triage Process

WATERTOWN, Mass., Oct. 1, 2015 (GLOBE NEWSWIRE) -- A new study published in American ...

author_avatar
NASDAQ Market News

Syapse Announces Collaboration with Pfizer in Oncology Precision Medicine Focused on Outcomes Research Using Real-World Evidence

author_avatar
NASDAQ Market News

Viral Vector & Plasmid DNA Manufacturing Market Research Report by Type, by Indication, by Workflow, by Application, by End User, by Region – Global Forecast to 2026 – Cumulative Impact of COVID-19

author_avatar
NASDAQ Market News